Search

Displaying results 8021 - 8030 of 10000 in total
  1. Drug

    Ricolinostat

    go.drugbank.com/drugs/DB12376
    Investigational

    Ricolinostat is under investigation for the treatment of Breast Carcinoma and Metastatic Breast Cancer.

  2. Drug

    Esreboxetine

    go.drugbank.com/drugs/DB12395
    Investigational

    Esreboxetine has been used in trials studying the treatment and basic science of Fibromyalgia.

  3. Drug

    PF-03635659

    go.drugbank.com/drugs/DB12408
    Investigational

    Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.

    Categories: Receptor, Muscarinic M3, antagonists & inhibitors
  4. Drug

    Lifibrol

    go.drugbank.com/drugs/DB12448
    Investigational

    Lifibrol has been used in trials studying the basic science of Hyperlipoproteinemia and Hypercholesterolemia.

  5. Drug

    Imeglimin

    go.drugbank.com/drugs/DB12509
    Investigational

    Imeglimin has been used in trials studying the treatment of Type 2 Diabetes Mellitus.

  6. Drug

    MK-5108

    go.drugbank.com/drugs/DB12556
    Investigational

    MK-5108 has been used in trials studying the treatment of Cancer, Neoplasms, Tumors.

  7. Drug

    4SC-203

    go.drugbank.com/drugs/DB12669
    Investigational

    4SC-203 has been used in trials studying the treatment of Acute Myeloid Leukemia.

  8. Drug

    1-benzylimidazole

    go.drugbank.com/drugs/DB04581
    Experimental

    1-benzylimidazole, an N-imidazole derivative, has been shown to have strong cardiotonic activity.

  9. Drug

    Serrapeptase

    go.drugbank.com/drugs/DB13131
    Investigational

    Serratiopeptidase is under investigation in clinical trial NCT02493179 (Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery).

  10. Drug

    ZD4407

    go.drugbank.com/drugs/DB06539
    Experimental

    The drug ZD4407, an antiasthmatic developed by AstraZeneca, functions as a 5-lipoxygenase inhibitor. … It entered Phase 1 clinical trials for chronic obstructive pulmonary disease (COPD) in the United Kingdom but was discontinued during this phase in March 2003